UTI AMC schedules analyst meet with institutional investors on June 11
UTI Asset Management Company Limited has scheduled a group meeting with analysts and institutional investors on June 11, 2026, at 1600 hrs IST at its Corporate Office in BKC, Mumbai. The meeting, conducted in person with senior management, includes participants such as Square 64 Capital Advisors LLP and Dand Family Office. The company confirmed that no unpublished price sensitive information will be shared, and the date remains subject to change.

*this image is generated using AI for illustrative purposes only.
UTI Asset Management Company Limited has scheduled a group meeting with analysts and institutional investors on June 11, 2026, at its Corporate Office in BKC, Mumbai. The interaction is set to take place at 1600 hrs IST and will be conducted in person with the company's senior management.
The disclosure was made pursuant to Regulation 30 read with Schedule III Part A Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company specified that no unpublished price sensitive information (UPSI) will be shared during the meeting.
The meeting will include four institutional participants. The list of attendees includes Square 64 Capital Advisors LLP, Dand Family Office, White Stone Financial Advisors Private Limited, and Credential Investments.
Meeting Schedule
| Date & Time | Name | Mode of the Meeting | Place |
|---|---|---|---|
| 11th June, 2026 at 1600 hrs IST | 1. Square 64 Capital Advisors LLP 2. Dand Family Office 3. White Stone Financial Advisors Private Limited 4. Credential Investments |
In person | Corporate Office, BKC, Mumbai |
The company noted that the date of the meeting is subject to change. Arvind Patkar, Company Secretary and Compliance Officer, signed the disclosure on behalf of UTI AMC.
Historical Stock Returns for UTI AMC
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.08% | -2.32% | -2.91% | -18.72% | -19.49% | +22.34% |
What strategic topics are likely to dominate the agenda given the specific mix of family offices and institutional investors attending?
Could this meeting signal a shift in UTI AMC's investor outreach strategy towards more focused, in-person engagements?
How might the outcomes of this meeting influence UTI AMC's stock performance in the short term despite the assurance of no UPSI being shared?

































